These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19660856)

  • 41. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innovations in endoscopic imaging for bladder cancer.
    Lerner SP
    Eur Urol; 2009 Dec; 56(6):920-2. PubMed ID: 19665285
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
    Bunce C; Ayres BE; Griffiths TR; Mostafid H; Kelly J; Persad R; Kockelbergh R
    BJU Int; 2010 Feb; 105 Suppl 2():2-7. PubMed ID: 20089091
    [No Abstract]   [Full Text] [Related]  

  • 44. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
    Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
    Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
    [No Abstract]   [Full Text] [Related]  

  • 45. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R; Shariat SF; Monoski MA; Lerner SP
    Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytogenetic analysis of false-positive mucosa by photodynamic diagnosis using 5-aminolevulinic acid - possible existence of premalignant genomic alterations examined by in vitro experiment.
    Matsuyama H; Yamamoto Y; Nagao K; Ohmi C; Sakano S; Sasaki K
    Oncology; 2009; 76(2):118-25. PubMed ID: 19158444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? No (a difficult task).
    O'Brien T
    J Urol; 2013 Jul; 190(1):20-1. PubMed ID: 23602484
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An audit of positive findings in flexible and rigid check cystoscopy.
    Keoghane SR; Ritchie AW; Jones DJ
    J R Army Med Corps; 1999 Oct; 145(3):143-4. PubMed ID: 10579170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder.
    Kaufman DS; Shipley WU; McDougal WS; Young RH
    N Engl J Med; 2004 Jan; 350(4):394-402. PubMed ID: 14736932
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
    BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
    Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
    BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?
    Shah JB; Kamat AM
    Cancer; 2011 Mar; 117(5):882-3. PubMed ID: 20960505
    [No Abstract]   [Full Text] [Related]  

  • 56. [Superficial bladder tumors. Pathological and clinical review and presentation of a new diagnostic method: fluorescence photodetection of transitional epithelial carcinomas based on protoporphyrin IX induction with delta-aminolevulinic acid (5-ALA)].
    Jichlinski P; Mizeret J; Forrer M; Wagnière G; Van den Bergh H; Schmidlin F; Graber P; Leisinger HJ
    Rev Med Suisse Romande; 1995 Mar; 115(3):233-7. PubMed ID: 7777763
    [No Abstract]   [Full Text] [Related]  

  • 57. Could basic research shed light on false positivity in photodynamic diagnosis?
    Matsuyama H
    Int J Urol; 2012 Aug; 19(8):695-6. PubMed ID: 22587444
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fluorescence cytology of the urinary bladder after instillation of 5-aminolevulinic acid].
    Tauber S
    Urologe A; 2007 Sep; 46(9):1123-5. PubMed ID: 17641864
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cystoscopic classification of transitional cell carcinoma of the bladder].
    Tochigi T; Nishimura Y; Fukuzaki A; Yoshikawa K; Hoshi S; Tanahashi Y; Orikasa S; Imai Y
    Nihon Hinyokika Gakkai Zasshi; 1985 Sep; 76(9):1357-67. PubMed ID: 4087629
    [No Abstract]   [Full Text] [Related]  

  • 60. [Photodynamic diagnosis (cystoscopy with hexaminolevulinate) in the surveillance of urothelial lesions managed with conservative treatment].
    Vordos D
    Ann Pathol; 2010 Nov; 30(5 Suppl 1):115-6. PubMed ID: 21055566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.